Latest Kaiser Health News Stories
The president, who has repeatedly pledged to improve health care and lower prescription drug prices, faces disapproval from a majority of Americans on his policies regarding drug costs, protecting people with preexisting conditions and the Affordable Care Act.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
For rural physicians, the burden of responding to the opioid epidemic falls squarely on their already loaded shoulders. For one doctor in a small Wisconsin village, there was no question that she wanted to rise to the challenge.
People with sickle cell disease aren’t fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
‘Medication insecurity’ is a thing.
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
KHN correspondent Shefali Luthra was among the guests on the podcast “Today, Explained” to talk about PrEP.
The Affordable Care Act has been on the books for nearly a decade. Parts of it have become ingrained in our health system ― and in our everyday life. But this could change, depending on a long-awaited 5th Circuit Court of Appeals decision regarding the law’s constitutionality.
KHN’s Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but don’t count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for “extra credit,” the panelists offer their favorite health stories of the week they think you should read, too.